Bioqual Past Earnings Performance

Past criteria checks 0/6

Bioqual's earnings have been declining at an average annual rate of -7.2%, while the Life Sciences industry saw earnings growing at 16.4% annually. Revenues have been growing at an average rate of 11.8% per year.

Key information

-7.2%

Earnings growth rate

-7.2%

EPS growth rate

Life Sciences Industry Growth21.5%
Revenue growth rate11.8%
Return on equity-1.2%
Net Margin-0.7%
Last Earnings Update30 Nov 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Bioqual makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:BIOQ Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Nov 23620120
31 Aug 23620120
31 May 23631120
28 Feb 23653110
30 Nov 22685110
31 Aug 22665100
31 May 22665100
28 Feb 22645100
30 Nov 21606100
31 Aug 21586100
31 May 2158690
28 Feb 2155590
30 Nov 2054580
31 Aug 2051580
31 May 2046480
29 Feb 2044470
30 Nov 1943470
31 Aug 1940470
31 May 1939370
28 Feb 1938340
30 Nov 1836340
31 Aug 1837440
31 May 1836430
28 Feb 1835330
30 Nov 1736330
31 Aug 1736430
31 May 1737430
28 Feb 1737430
30 Nov 1637430
31 Aug 1636430
31 May 1633330
29 Feb 1631230
30 Nov 1529230
31 Aug 1529230
31 May 1529230
28 Feb 1529230
30 Nov 1426130
31 Aug 1423130
31 May 1422130
28 Feb 1419130
30 Nov 1319030
31 Aug 1319030
31 May 1320030

Quality Earnings: BIOQ is currently unprofitable.

Growing Profit Margin: BIOQ is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BIOQ is unprofitable, and losses have increased over the past 5 years at a rate of 7.2% per year.

Accelerating Growth: Unable to compare BIOQ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BIOQ is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-9.3%).


Return on Equity

High ROE: BIOQ has a negative Return on Equity (-1.19%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.